JACLYN DRASS: Open Payments
NPI 1831678390 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,082 in 154 payments from 22 companies in 2025. Trend: 2023 $2,866 · 2024 $3,319 · 2025 $3,082
Food & beverage: $3,082
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $433 |
| PFIZER INC. | 12 | $269 |
| Novo Nordisk Inc | 9 | $266 |
| Abbott Laboratories | 8 | $265 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $248 |
| Corium, LLC | 9 | $232 |
| Lundbeck LLC | 13 | $230 |
| Otsuka America Pharmaceutical, Inc. | 10 | $210 |
| ABBVIE INC. | 19 | $204 |
| Lilly USA, LLC | 10 | $166 |
Products named: REXULTI, JARDIANCE, FREESTYLE LIBRE 3, Azstarys, AIRSUPRA, FARXIGA, Wegovy, MOUNJARO.
Industry payments across OK — which companies pay providers there.
